Musculoskeletal signs and symptoms E. The fibromyalgia syndrome

Primer on the Rheumatic Diseases: Thirteenth Edition

Volumn , Issue , 2008, Pages 87-93

  Dadabhoy, Dina ^a   Clauw, Daniel J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77949314065     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-68566-3_3     Document Type: Chapter

References (10)

1. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-172.
2. Granges G, Littlejohn G. Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis Rheum 1993;36:642-646.
3. Arnold LM, Hudson JI, Hess EV, et al. Family study of fibromyalgia. Arthritis Rheum 2004;50:944-952.
4. Buskila D, Neumann L. Genetics of fibromyalgia. Curr Pain Headache Rep 2005;9:313-315.
5. Russell IJ, Orr MD, Littman B, et al. Elevated cerebro-spinal fluid levels of substance P in patients with the fibro-myalgia syndrome. Arthritis Rheum 1994;37:1593-1601.
6. Julien N, Goffaux P, Arsenault P, Marchand S. Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 2005;114:295-302.
7. Crofford LJ. Neuroendocrine abnormalities in fibromyal-gia and related disorders. Am J Med Sci 1998;315:359-366.
8. Gracely RH, Geisser ME, Giesecke T, et al. Pain catastro-phizing and neural responses to pain among persons with fibromyalgia. Brain 2004;127:835-843.
9. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA 2004;292:2388-2395.
10. Hadler NM. Fibromyalgia, chronic fatigue, and other iat-rogenic diagnostic algorithms. Do some labels escalate illness in vulnerable patients?. Postgrad Med 1997;102:161-166, 171.